V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20093076 | 20087089 | 1.58 | 46.9 | 03 | 2015-04-15 | 2015-04-23 | null | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101277618 |
| 20093216 | 20087090 | 1.7 | 91.7 | Palliative (P) | null | 2022-05-26 | EOF | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100788228 |
| 20093851 | 20087091 | 1.59 | 104 | 03 | 2018-04-21 | 2018-04-21 | Sunitinib | null | Y | RALTITREXED | 100023025 |
| 20094404 | 20087092 | 1.71 | 59.85 | 03 | 2016-03-10 | 2016-03-15 | PLATO Trials | N | N | PLATO TRIAL | 101436212 |
| 20095247 | 20087093 | 1.8 | 78.5 | Palliative (P) | 2016-01-14 | 2016-02-04 | CAPECITABINE + CARBOPLATIN + Trastuzumab | N | N | CAPITAL TRIAL | 100658896 |
| 20095573 | 20087095 | 1.54 | 94.4 | Neo-adjuvant (N) | 2016-07-11 | 2016-07-21 | ESPAC-4 TRIAL | 02 | N | BACILLUS CALMETTE-GUERIN | 101080666 |
| 20095990 | 20087097 | 1.71 | 65 | Palliative (P) | 2018-01-12 | 2018-01-18 | Raltitrexed | 02 | N | CAPECITABINE + STREPTOZOCIN | 100743700 |
| 20096483 | 20087098 | 1.73 | 55.9 | null | 2018-10-30 | 2018-11-07 | null | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100931744 |
| 20096505 | 20087099 | 1.52 | 46 | Palliative (P) | 2018-09-26 | 2018-10-03 | ECarboF | 02 | N | ECARBOX | 100698877 |
| 20096764 | 20087100 | 1.64 | 77 | Palliative (P) | 2016-03-24 | 2016-07-20 | Azacitidine | N | N | CISPLATIN + FLUOROURACIL + RT | 100025524 |
| 20097129 | 20087102 | 1.52 | 57.7 | 03 | 2016-10-13 | 2016-10-23 | PEMBROLIZUMAB | N | N | CISPLATIN + FLUOROURACIL + RT | 100407652 |
| 20097335 | 20087103 | null | 95.5 | Palliative (P) | 2018-04-15 | 2018-04-16 | GO2 TRIAL | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100516175 |
| 20097616 | 20087104 | 1.83 | 62.4 | Palliative (P) | null | 2020-03-11 | null | Y | N | RITUXIMAB | 100933755 |
| 20097826 | 20087106 | 1.66 | 43.6 | Adjuvant (A) | null | 2016-07-26 | Gemcitabine + Paclitaxel | 01 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100024902 |
| 20097863 | 20087107 | 1.76 | 55.8 | 03 | 2019-12-24 | 2020-01-02 | R-GEM-P | 02 | N | BCG | 101509170 |
| 20098516 | 20087108 | 1.77 | 80.2 | 03 | 2017-02-07 | 2017-02-08 | Gemcitabine + Oxaliplatin | 02 | N | DOCETAXEL | 101422240 |
| 20098653 | 20087109 | 1.88 | 59.8 | Palliative (P) | 2017-07-16 | 2017-08-16 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | DOCETAXEL | 100930089 |
| 20098699 | 20087110 | 1.74 | 71.4 | Palliative (P) | null | 2019-08-10 | null | N | N | IXAZOMIB + LENALIDOMIDE | 101156006 |
| 20098742 | 20087111 | 1.73 | 102.5 | Palliative (P) | 2016-12-20 | 2016-12-21 | HEP HR Hepatoblastoma guide cisp | 01 | N | INTERAACT TRIAL | 101209727 |
| 20098972 | 20087112 | 1.76 | 46 | Adjuvant (A) | 2018-12-17 | 2018-12-17 | CARBOPLATIN + GEMCITABINE | 02 | N | PANITUMUMAB | 100251449 |
| 20099075 | 20087113 | 1.64 | 127.2 | Palliative (P) | 2020-01-27 | 2020-01-27 | SCOPE 2 TRIAL | 02 | N | ACTICCA-1 TRIAL | 101116287 |
| 20099293 | 20087114 | 1.54 | 96.85 | 03 | 2019-01-20 | 2019-01-22 | Letrozole + Palbociclib | 02 | N | ACELARATE TRIAL | 101037736 |
| 20100333 | 20087118 | 1.68 | 80 | null | 2017-02-07 | 2017-02-07 | PEMBROLIZUMAB | 02 | N | PANITUMUMAB | 101160754 |
| 20100888 | 20087119 | 1.69 | 91.4 | Palliative (P) | 2019-03-03 | 2019-03-04 | Raltitrexed | 02 | N | ACTICCA-1 TRIAL | 100895278 |
| 20101314 | 20087120 | 1.8 | 65.3 | Palliative (P) | 2018-11-02 | 2018-11-02 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101124642 |
| 20101707 | 20087121 | 1.66 | 119.5 | null | null | 2016-12-29 | NIVOLUMAB | 02 | N | CISPLATIN + VINORELBINE | 100638942 |
| 20102118 | 20087122 | 1.7 | 82 | Adjuvant (A) | 2022-04-03 | 2022-04-15 | null | 02 | N | SCOPE2 TRIAL | 101492115 |
| 20102659 | 20087123 | 0.89 | 91 | Palliative (P) | null | 2017-07-13 | Erlotinib | N | N | CNS ATRT DOX | 100699399 |
| 20102709 | 20087124 | 1.66 | 68.5 | 03 | 2018-10-12 | 2018-10-12 | PLATO Trials | 02 | N | PLATO TRIAL | 100699180 |
| 20103132 | 20087126 | 1.6 | 63.9 | Palliative (P) | 2017-11-14 | 2017-11-18 | Capital Trial | N | N | CAP + RT | 100983899 |
| 20103204 | 20087127 | 1.62 | 68 | Palliative (P) | 2019-03-22 | 2019-04-06 | Ipilimumab | 02 | N | PLATFORM TRIAL | 100116750 |
| 20103311 | 20087128 | 1.55 | 56.8 | Adjuvant (A) | 2017-11-13 | 2017-11-13 | Capecitabine + Streptozocin | 02 | N | OXALIPLATIN | 100700222 |
| 20103390 | 20087130 | 1.66 | 77.8 | Curative (C) | 2016-05-19 | 2016-05-22 | Capecitabine + Streptozocin | null | N | ACTICCA-1 TRIAL | 101721714 |
| 20103503 | 20087131 | 1.84 | 74 | Adjuvant (A) | 2019-07-19 | 2019-08-09 | PRICKLE trial | N | N | ACTICCA-1 TRIAL | 101352486 |
| 20103600 | 20087132 | 1.7 | 79 | Palliative (P) | 2019-08-08 | 2019-08-08 | FCR | 02 | N | ACELARATE TRIAL | 100055026 |
| 20103732 | 20087133 | 1.49 | 68 | 03 | 2021-12-10 | 2021-12-10 | OXALIPLATIN | N | N | POMALIDOMIDE | 100835780 |
| 20104579 | 20087134 | 1.96 | 61.1 | Palliative (P) | 2018-02-01 | 2018-02-01 | Capecitabine + Streptozocin | 01 | N | EVEROLIMUS | 101197827 |
| 20104797 | 20087136 | 1.7 | 71.8 | Palliative (P) | 2016-12-13 | 2016-12-17 | Paclitaxel 7 day | 02 | N | PEMBROLIZUMAB | 100114065 |
| 20104843 | 20087137 | 1.81 | 47.55 | Palliative (P) | 2016-09-10 | 2016-09-11 | IPILIMUMAB + NIVOLUMAB | 02 | N | RALTITREXED | 101336849 |
| 20104849 | 20087138 | 0 | 0 | Palliative (P) | 2018-10-01 | 2018-10-04 | null | N | N | PRIMUS 002 TRIAL | 101653900 |
| 20104901 | 20087139 | 1.44 | 64 | Palliative (P) | 2019-07-12 | 2019-07-12 | Carbo F | 01 | N | EVEROLIMUS | 100894881 |
| 20104903 | 20087140 | 1.74 | 77.4 | 03 | 2017-07-11 | 2017-07-14 | IRINOTECAN + MDG + PANITUMUMAB | N | N | CETUXIMAB + RT | 101304581 |
| 20104922 | 20087141 | 1.47 | 59.6 | Palliative (P) | 2017-10-22 | 2017-10-28 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | ACTICCA-1 TRIAL | 101488857 |
| 20105047 | 20087142 | 1.74 | 95 | null | 2017-03-17 | 2017-03-19 | Gemcitabine + Paclitaxel | 02 | N | RUXOLITINIB | 101572681 |
| 20105104 | 20087143 | 1.78 | 67.9 | 03 | 2019-05-05 | 2019-05-13 | REGORAFENIB | N | N | DOXORUBICIN | 101156254 |
| 20105167 | 20087144 | 1.58 | 78.6 | 03 | 2018-06-01 | 2018-06-15 | MITOMYCIN | 02 | N | IFOSFAMIDE | 101586936 |
| 20105220 | 20087145 | 1.75 | 0.1 | null | 2019-06-02 | 2019-06-02 | ESPAC-4 TRIAL | 01 | N | ECARBOX | 101652514 |
| 20105531 | 20087149 | null | null | 03 | 2020-08-03 | 2020-08-04 | null | 01 | N | OXALIPLATIN | 100928880 |
| 20105537 | 20087150 | 1.54 | 0 | null | 2018-11-10 | 2018-11-23 | TEMOZOLOMIDE | 02 | N | CAPECITABINE + STREPTOZOCIN | 101617834 |
| 20105539 | 20087151 | 1.83 | 76.7 | Adjuvant (A) | 2018-08-06 | 2018-08-10 | CVP R | Y | N | OXALIPLATIN | 101217507 |